Efemoral Medical Granted Breakthrough Device Designation
Novel bioresorbable scaffold system being developed for expanded indications

Sartorius Forms Partnership with SPARTA Biodiscovery on Novel Nanoparticle Analysis Platform
The life science group Sartorius and UK-based startup SPARTA Biodiscovery have agreed to partner on SPARTA’s analysis platform, which helps speed up the development, manufacture, and quality control of nanoparticles for biopharmaceutical drugs. Nanoparticles are small polymer or lipid capsules that act as carriers to deliver active agents to the target cells. As part of the cooperation, Sartorius will invest up to 3.5 million British pounds in a minority shareholding in SPARTA Biodiscovery through its corporate investment unit Sartorius Ventures.

Sartorius completes acquisition of Polyplus
The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has successfully closed the acquisition of the French company Polyplus. The transaction was completed on July 18, 2023, after receiving the required regulatory approvals.